| Parent directory | - | - |
| Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters_ Nav..> | 208 B | 2024-Aug-12 12:00 |
| Consideration of the Aerosol Transmission for COVID-19_ risa.13500.pdf | 114.3 KiB | 2020-May-13 00:04 |
| Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273_Steensels et al_ jama 2021.pdf | 148.5 KiB | 2021-Sep-01 00:01 |
| Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 2020.04.01.20047381v1.full.pdf | 159.1 KiB | 2020-Apr-09 22:17 |
| Lung Recruitability in SARS-CoV-2 Associated Acute Respiratory Distress Syndrome_ alternating laying on back and stomach i..> | 179.8 KiB | 2020-Mar-25 19:28 |
| Evaluation of Five Decontamination Methods for Filtering Facepiece Respirators_ D J Viscusi_ M S Bergman_ B C Eimer_ R E S..> | 181.5 KiB | 2020-May-15 01:00 |
| Effect of Decontamination on the Filtration Efficiency of Two Filtering Facepiece Respirator Models_ Dennis J Viscusi_ Wil..> | 220.4 KiB | 2020-May-15 00:59 |
| Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants_ L J Abu-Raddad et al_ nejm 2021.pdf | 296.7 KiB | 2021-May-06 00:16 |
| Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients_ J A Lednicky et al_ 2020.pdf | 312.0 KiB | 2020-Aug-06 19:07 |
| Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Co..> | 359.3 KiB | 2020-Aug-06 16:16 |
| SARS-CoV-2 variants as super cell fusers_ cause or consequence of COVID-19 severity_ embj.2021110041.pdf | 361.3 KiB | 2021-Dec-03 15:08 |
| Quantitative form and fit of N95 filtering facepiece respirators are retained and coronavirus surrogate_ T Massey_ M Boruc..> | 383.5 KiB | 2020-May-15 18:05 |
| Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals_ Shay ..> | 400.4 KiB | 2021-Apr-11 03:21 |
| SARS-CoV-2 invades host cells via a novel route: CD147-spike protein.pdf | 450.4 KiB | 2020-Mar-20 18:28 |
| Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence_ Daniele Focosi_ Fabrizio Maggi_ Arturo Cas..> | 517.8 KiB | 2022-May-16 00:29 |
| Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study_ D Ayoubkhani et al_ bmj..> | 529.2 KiB | 2021-Apr-09 16:35 |
| Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant_ arxiv2022.01.13.22269257v1.pdf | 576.9 KiB | 2022-Feb-07 19:28 |
| Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus_ implications for virus ..> | 615.5 KiB | 2020-Dec-18 19:05 |
| Persistent immune imprinting after XBB.1.5 COVID vaccination in humans_ bioarxiv_2023.11.28.569129v1.full.pdf | 648.0 KiB | 2023-Dec-03 19:12 |
| Aerosol and surface stability of HCoV-19 SARS-CoV-2 compared to SARS-CoV-1_ Neeltje van Doremalen et al_ 2020.pdf | 667.8 KiB | 2020-Mar-26 19:27 |
| Intranasal vaccination should block SARS-CoV-2 transmission at the source_ Scent of a vaccine_ Frances E Lund_ Troy D Ran..> | 721.1 KiB | 2021-Jul-23 17:24 |
| The effect of temperature on persistence of SARS-CoV-2 on common surfaces_ S Riddell_ S Goldie_ A Hill_ D Eagles_ T W Drew..> | 888.2 KiB | 2020-Oct-11 17:40 |
| Effectiveness of Covid-19 vaccination against risk of symptomatic infection, hospitalization, and death up to 9 months_ a ..> | 962.4 KiB | 2021-Nov-05 23:50 |
| RaDVaC SARS-CoV-2 vaccine_ White-Paper-3-3-1_ 2020.pdf | 1.1 MiB | 2020-Dec-12 19:41 |
| Endonuclease fingerprint indicates a synthetic origin of SARS-CoV-2_ bioaxiv2022.10.18.512756v1.full.pdf | 1.2 MiB | 2022-Oct-21 01:33 |
| RaDVaC SARS-CoV-2 vaccine_ White-Paper-ver-4-1-1.pdf | 1.2 MiB | 2021-Mar-09 18:49 |
| Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus_ Vincent J Munster et al_ 2020.pdf | 1.2 MiB | 2020-Sep-08 22:46 |
| The airborne transmission of viruses causes tight transmission bottlenecks_ P Sinclair_ L Zhao_C B. Beggs_ C J R Illingwor..> | 1.3 MiB | 2024-Sep-18 20:03 |
| The Dynamics of SARS-CoV-2 Infectivity with Changes in Aerosol Microenvironment_ H P Oswin et al_ 2022.pdf | 1.4 MiB | 2022-Jan-23 15:00 |
| An upper bound on one-to-one exposure to infectious human respiratory particles_ G Bagheri et al_ PNAS 2021.pdf | 1.5 MiB | 2022-Jan-14 05:01 |
| COVID-19 Antibody Seroprevalence in Santa Clara County, California 2020.04.14.20062463v1.full.pdf | 1.5 MiB | 2020-Apr-17 19:56 |
| Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron_ O Puhach et ..> | 1.6 MiB | 2022-Jan-21 15:32 |
| Disposable masks_ Disinfection and sterilization for reuse and non-certified manufacturing, in the face of shortages durin..> | 1.8 MiB | 2020-May-15 01:09 |
| Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2.pdf | 1.9 MiB | 2020-Mar-19 22:33 |
| Deciphering the TCR Repertoire to Solve the COVID-19 Mystery_ Lucas Gutierrez_ John Beckford_ Houda Alachkar_ 2020.pdf | 1.9 MiB | 2020-Jul-09 18:01 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinat..> | 1.9 MiB | 2023-Mar-10 01:27 |
| B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal ant..> | 2.0 MiB | 2021-Apr-23 16:04 |
| Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response_ L C Nguyen_ D Yang_ V Nicolaescu..> | 2.0 MiB | 2021-Aug-12 22:51 |
| Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 COVID-1..> | 2.0 MiB | 2020-Jul-30 16:33 |
| Universal Masking is Urgent in the COVID-19 Pandemic_ SEIR and Agent Based Models, Empirical Validation, Policy Recommenda..> | 2.1 MiB | 2020-Jun-01 23:05 |
| Quantity of SARS-CoV-2 RNA copies exhaled per minute during natural breathing over the course of COVID-19 infection_ Grego..> | 2.1 MiB | 2023-Sep-12 15:14 |
| SARS-CoV-2 Infects Peripheral and Central Neurons of Mice Before Viremia, Facilitated by Neuropilin-1_ bioarxiv2022.05.20...> | 2.3 MiB | 2022-May-24 21:58 |
| Speech can produce jet-like transport relevant to asymptomatic spreading of virus_ Manouk Abkarian_ Simon Mendez_ Nan Xue_..> | 2.4 MiB | 2020-Oct-16 16:55 |
| Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination_ 2023.01.25.525485v1.full.pdf | 2.4 MiB | 2023-Jan-26 23:46 |
| COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system_ S Rysz et al_ Nature C..> | 2.4 MiB | 2021-Apr-23 16:22 |
| Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave_ S T Tan_ A T Kwan_ I R-G_ B..> | 2.7 MiB | 2023-Jan-04 05:43 |
| SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation_ embj.2021108944.pdf | 2.7 MiB | 2021-Dec-03 15:05 |
| Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters_ Lee..> | 2.9 MiB | 2024-Aug-11 16:30 |
| Recharging and rejuvenation of decontaminated N95 masks_ E Hossain_ S Bhadra_ H Jain_ S Das_ A Bhattacharya_ S Chosh_ D Le..> | 3.0 MiB | 2020-Sep-14 23:13 |
| Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses_ Tianyang ..> | 3.5 MiB | 2022-Jan-27 14:34 |
| A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19_ James..> | 3.8 MiB | 2021-Sep-25 23:59 |
| An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models _ Leekha A et al_ natcomm 2..> | 4.2 MiB | 2024-Aug-23 20:05 |
| Can N95 Respirators Be Reused after Disinfection_ How Many Times_ Lei Liao_ Wang Xiao_ Mervin Zhao_ Xuanze Yu_ Haotian Wan..> | 4.3 MiB | 2020-May-15 01:17 |
| Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates_ Daniel C Dou..> | 4.4 MiB | 2024-Sep-03 16:53 |
| Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity_ Meng B_ Abdullahi A_ Ferreira IA TM et a..> | 10.5 MiB | 2022-Mar-24 20:05 |
| Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity_ Yao et al_ 2..> | 10.6 MiB | 2022-Feb-21 05:47 |
| Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and var..> | 13.5 MiB | 2022-Feb-21 05:09 |
| Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7_ P Wang et al_ Nature 2021.pdf | 13.7 MiB | 2021-Mar-08 22:21 |
| Evolution of antibody immunity to SARS-CoV-2_ C Gaebler et al_ Nature 2021.pdf | 13.9 MiB | 2021-Apr-05 20:57 |
| A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic_ Tirosh Shapira et al_ Nature 2022.pdf | 14.3 MiB | 2022-Mar-29 20:36 |
| Filter quality of electret masks in filtering 14.6-594 nm aerosol particles_ Effects of five decontamination methods.pdf | 17.7 MiB | 2020-Mar-27 23:13 |
| Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma_ S Cele et al_ Nature 2021.pdf | 21.2 MiB | 2021-Apr-09 16:36 |
| Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia_ Luca Braga et al_ Nature 2021.pdf | 56.5 MiB | 2021-Apr-11 04:19 |
| USGS-DEFUSE-2021-006245-Combined-Records_Redacted.pdf | 71.8 MiB | 2024-Feb-29 01:27 |
7 days, 31 days